ID   CL12B_HUMAN             Reviewed;         276 AA.
AC   Q2HXU8; Q6UWF2; Q6ZRG0;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 1.
DT   03-AUG-2022, entry version 127.
DE   RecName: Full=C-type lectin domain family 12 member B;
DE   AltName: Full=Macrophage antigen H {ECO:0000303|PubMed:17562706};
GN   Name=CLEC12B {ECO:0000303|PubMed:34310951,
GN   ECO:0000312|HGNC:HGNC:31966}; ORFNames=UNQ5782/PRO16089;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION,
RP   SUBUNIT, INTERACTION WITH PTPN6 AND PTPN11, TISSUE SPECIFICITY, INDUCTION,
RP   DOMAIN, MUTAGENESIS OF TYR-7, PHOSPHORYLATION AT TYR-7, AND ALTERNATIVE
RP   SPLICING.
RX   PubMed=17562706; DOI=10.1074/jbc.m704250200;
RA   Hoffmann S.C., Schellack C., Textor S., Konold S., Schmitz D., Cerwenka A.,
RA   Pflanz S., Watzl C.;
RT   "Identification of CLEC12B, an inhibitory receptor on myeloid cells.";
RL   J. Biol. Chem. 282:22370-22375(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT LEU-116.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS ASN-6 AND
RP   LEU-116.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   FUNCTION, TISSUE SPECIFICITY, PTM, INTERACTION WITH PTPN11, DOMAIN, AND
RP   MUTAGENESIS OF TYR-7.
RX   PubMed=34310951; DOI=10.1016/j.jid.2021.05.035;
RA   Montaudie H., Sormani L., Dadone-Montaudie B., Heim M., Cardot-Leccia N.,
RA   Tulic M.K., Beranger G., Gay A.S., Debayle D., Cheli Y., Raymond J.H.,
RA   Sohier P., Petit V., Rocchi S., Gesbert F., Larue L., Passeron T.;
RT   "CLEC12B Decreases Melanoma Proliferation by Repressing Signal Transducer
RT   and Activator of Transcription 3.";
RL   J. Invest. Dermatol. 142:425-434(2022).
CC   -!- FUNCTION: Inhibitory receptor postulated to negatively regulate immune
CC       and non-immune functions (PubMed:17562706, PubMed:34310951). Upon
CC       phosphorylation, recruits SH2 domain-containing PTPN6 and PTPN11
CC       phosphatases to its ITIM motif and antagonizes activation signals
CC       (PubMed:17562706, PubMed:34310951). Although it inhibits KLRK1/NKG2D-
CC       mediated signaling, it does not bind known ligands of KLRK1/NKG2D and
CC       therefore is not its inhibitory counterpart (PubMed:17562706). May
CC       limit activation of myeloid cell subsets in response to infection or
CC       tissue inflammation (PubMed:17562706). May protect target cells against
CC       natural killer cell-mediated lysis (PubMed:17562706). May negatively
CC       regulate cell cycle and differentiation of melanocytes via inactivation
CC       of STAT3 (PubMed:34310951). {ECO:0000269|PubMed:17562706,
CC       ECO:0000269|PubMed:34310951}.
CC   -!- SUBUNIT: Homodimer. Interacts (via ITIM motif) with PTPN6
CC       (PubMed:17562706). Interacts (via ITIM motif) with PTPN11; this
CC       interaction triggers dephosphorylation and activation of PTPN11
CC       (PubMed:17562706, PubMed:34310951). {ECO:0000269|PubMed:17562706,
CC       ECO:0000269|PubMed:34310951}.
CC   -!- INTERACTION:
CC       Q2HXU8-2; Q01638-2: IL1RL1; NbExp=3; IntAct=EBI-12811991, EBI-12838366;
CC       Q2HXU8-2; Q8N5M9: JAGN1; NbExp=3; IntAct=EBI-12811991, EBI-10266796;
CC       Q2HXU8-2; Q9UBY5: LPAR3; NbExp=3; IntAct=EBI-12811991, EBI-12033434;
CC       Q2HXU8-2; Q8N112: LSMEM2; NbExp=3; IntAct=EBI-12811991, EBI-10264855;
CC       Q2HXU8-2; Q13021: MALL; NbExp=3; IntAct=EBI-12811991, EBI-750078;
CC       Q2HXU8-2; P35372-10: OPRM1; NbExp=3; IntAct=EBI-12811991, EBI-12807478;
CC       Q2HXU8-2; Q9Y342: PLLP; NbExp=3; IntAct=EBI-12811991, EBI-3919291;
CC       Q2HXU8-2; Q01453: PMP22; NbExp=3; IntAct=EBI-12811991, EBI-2845982;
CC       Q2HXU8-2; O00767: SCD; NbExp=3; IntAct=EBI-12811991, EBI-2684237;
CC       Q2HXU8-2; Q96IW7: SEC22A; NbExp=3; IntAct=EBI-12811991, EBI-8652744;
CC       Q2HXU8-2; Q3ZAQ7: VMA21; NbExp=3; IntAct=EBI-12811991, EBI-1055364;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17562706};
CC       Single-pass type II membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q2HXU8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q2HXU8-2; Sequence=VSP_030034, VSP_030035;
CC   -!- TISSUE SPECIFICITY: Detected in colon, heart, kidney, liver, lung,
CC       mammary gland, ovary, spleen and testis (PubMed:17562706). Expressed in
CC       melanocytes (at protein level) (PubMed:34310951).
CC       {ECO:0000269|PubMed:17562706, ECO:0000269|PubMed:34310951}.
CC   -!- INDUCTION: Up-regulated upon differentiation of monocytes to
CC       macrophages. {ECO:0000269|PubMed:17562706}.
CC   -!- DOMAIN: Contains 1 copy of a cytoplasmic motif that is referred to as
CC       the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is
CC       involved in modulation of cellular responses. The phosphorylated ITIM
CC       motif can bind the SH2 domain of several SH2-containing phosphatases.
CC       {ECO:0000269|PubMed:17562706, ECO:0000269|PubMed:34310951}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:34310951}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ368812; ABC96323.1; -; mRNA.
DR   EMBL; AY358810; AAQ89170.1; -; mRNA.
DR   EMBL; AK128243; BAC87350.1; -; mRNA.
DR   EMBL; CH471094; EAW96136.1; -; Genomic_DNA.
DR   CCDS; CCDS44830.1; -. [Q2HXU8-1]
DR   CCDS; CCDS8610.1; -. [Q2HXU8-2]
DR   RefSeq; NP_001123470.1; NM_001129998.2. [Q2HXU8-1]
DR   RefSeq; NP_995324.2; NM_205852.3. [Q2HXU8-2]
DR   AlphaFoldDB; Q2HXU8; -.
DR   SMR; Q2HXU8; -.
DR   BioGRID; 132463; 217.
DR   IntAct; Q2HXU8; 11.
DR   STRING; 9606.ENSP00000344563; -.
DR   GlyGen; Q2HXU8; 3 sites.
DR   iPTMnet; Q2HXU8; -.
DR   PhosphoSitePlus; Q2HXU8; -.
DR   BioMuta; CLEC12B; -.
DR   DMDM; 121941174; -.
DR   MassIVE; Q2HXU8; -.
DR   MaxQB; Q2HXU8; -.
DR   PaxDb; Q2HXU8; -.
DR   PeptideAtlas; Q2HXU8; -.
DR   PRIDE; Q2HXU8; -.
DR   Antibodypedia; 57539; 69 antibodies from 18 providers.
DR   DNASU; 387837; -.
DR   Ensembl; ENST00000338896.11; ENSP00000344563.5; ENSG00000256660.7. [Q2HXU8-1]
DR   Ensembl; ENST00000396502.5; ENSP00000379759.1; ENSG00000256660.7. [Q2HXU8-2]
DR   Ensembl; ENST00000544853.5; ENSP00000439561.1; ENSG00000256660.7. [Q2HXU8-2]
DR   GeneID; 387837; -.
DR   KEGG; hsa:387837; -.
DR   MANE-Select; ENST00000338896.11; ENSP00000344563.5; NM_001129998.3; NP_001123470.1.
DR   UCSC; uc001qwx.3; human. [Q2HXU8-1]
DR   CTD; 387837; -.
DR   DisGeNET; 387837; -.
DR   GeneCards; CLEC12B; -.
DR   HGNC; HGNC:31966; CLEC12B.
DR   HPA; ENSG00000256660; Group enriched (bone marrow, skin, testis).
DR   MIM; 617573; gene.
DR   neXtProt; NX_Q2HXU8; -.
DR   OpenTargets; ENSG00000256660; -.
DR   PharmGKB; PA162382325; -.
DR   VEuPathDB; HostDB:ENSG00000256660; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   GeneTree; ENSGT00940000162751; -.
DR   HOGENOM; CLU_049894_5_1_1; -.
DR   InParanoid; Q2HXU8; -.
DR   OMA; IMFLQMS; -.
DR   PhylomeDB; Q2HXU8; -.
DR   TreeFam; TF336674; -.
DR   PathwayCommons; Q2HXU8; -.
DR   SignaLink; Q2HXU8; -.
DR   BioGRID-ORCS; 387837; 11 hits in 1064 CRISPR screens.
DR   ChiTaRS; CLEC12B; human.
DR   GenomeRNAi; 387837; -.
DR   Pharos; Q2HXU8; Tbio.
DR   PRO; PR:Q2HXU8; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q2HXU8; protein.
DR   Bgee; ENSG00000256660; Expressed in monocyte and 84 other tissues.
DR   ExpressionAtlas; Q2HXU8; baseline and differential.
DR   Genevisible; Q2HXU8; HS.
DR   GO; GO:0009897; C:external side of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0032991; C:protein-containing complex; IMP:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0019903; F:protein phosphatase binding; IDA:UniProtKB.
DR   GO; GO:0030547; F:signaling receptor inhibitor activity; IMP:UniProtKB.
DR   GO; GO:0097325; P:melanocyte proliferation; IDA:UniProtKB.
DR   GO; GO:0002769; P:natural killer cell inhibitory signaling pathway; IMP:UniProtKB.
DR   GO; GO:0045953; P:negative regulation of natural killer cell mediated cytotoxicity; IMP:UniProtKB.
DR   GO; GO:1904893; P:negative regulation of receptor signaling pathway via STAT; IDA:UniProtKB.
DR   GO; GO:2000272; P:negative regulation of signaling receptor activity; IMP:UniProtKB.
DR   CDD; cd03593; CLECT_NK_receptors_like; 1.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR042916; CLEC12A/B.
DR   InterPro; IPR016187; CTDL_fold.
DR   InterPro; IPR013600; Ly49_N.
DR   InterPro; IPR033992; NKR-like_CTLD.
DR   PANTHER; PTHR47647; PTHR47647; 1.
DR   Pfam; PF00059; Lectin_C; 1.
DR   Pfam; PF08391; Ly49; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Disulfide bond; Glycoprotein; Lectin;
KW   Membrane; Phosphoprotein; Receptor; Reference proteome; Signal-anchor;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..276
FT                   /note="C-type lectin domain family 12 member B"
FT                   /id="PRO_0000313581"
FT   TOPO_DOM        1..43
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        44..64
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        65..276
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          150..264
FT                   /note="C-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   MOTIF           5..10
FT                   /note="ITIM motif"
FT                   /evidence="ECO:0000303|PubMed:17562706"
FT   MOD_RES         7
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:17562706"
FT   CARBOHYD        91
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        176
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        237
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        172..263
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DISULFID        242..255
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   VAR_SEQ         228..232
FT                   /note="FSTKE -> YVSNY (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12975309,
FT                   ECO:0000303|PubMed:14702039"
FT                   /id="VSP_030034"
FT   VAR_SEQ         233..276
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12975309,
FT                   ECO:0000303|PubMed:14702039"
FT                   /id="VSP_030035"
FT   VARIANT         6
FT                   /note="T -> N (in dbSNP:rs1359082)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_037670"
FT   VARIANT         116
FT                   /note="V -> L (in dbSNP:rs637790)"
FT                   /evidence="ECO:0000269|PubMed:12975309,
FT                   ECO:0000269|PubMed:14702039"
FT                   /id="VAR_037671"
FT   MUTAGEN         7
FT                   /note="Y->F: Abolishes tyrosine phosphorylation and
FT                   inhibitory receptor activity. Abolishes interaction with
FT                   PTPN6 and PTPN11. Abolishes protection against natural
FT                   killer cell-mediated cytotoxicity."
FT                   /evidence="ECO:0000269|PubMed:17562706,
FT                   ECO:0000269|PubMed:34310951"
SQ   SEQUENCE   276 AA;  31616 MW;  3FD95A30C5C1BAC4 CRC64;
     MSEEVTYATL TFQDSAGARN NRDGNNLRKR GHPAPSPIWR HAALGLVTLC LMLLIGLVTL
     GMMFLQISND INSDSEKLSQ LQKTIQQQQD NLSQQLGNSN NLSMEEEFLK SQISSVLKRQ
     EQMAIKLCQE LIIHTSDHRC NPCPKMWQWY QNSCYYFTTN EEKTWANSRK DCIDKNSTLV
     KIDSLEEKDF LMSQPLLMFS FFWLGLSWDS SGRSWFWEDG SVPSPSLFST KELDQINGSK
     GCAYFQKGNI YISRCSAEIF WICEKTAAPV KTEDLD
//
